Status:
UNKNOWN
Human Bone Graft in Epiphysiodesis
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Surgebright Gmbh
Conditions:
Leg Length Differences
Primordial Gigantism
Eligibility:
All Genders
10-18 years
Brief Summary
This observational study is to document the application of human bone graft in the surgical treatment (epiphysiodesis) of leg length discrepancy or primordial gigantism and its subsequent healing proc...
Eligibility Criteria
Inclusion
- Planned epiphysiodesis to stop the growing of a bone indicated by leg length discrepancies or primordial gigantism
- Age 10-18 years
- Written consent to participate in the study after previous written and oral education (additional consent for the participation of minors in the study after prior written and oral education by at least one parent)
Exclusion
- Insufficient knowledge of the german language
- Foreseeable compliance issues
- Neoplastic diseases, malignant bone tumors, rheumatoid arthritis
- Patients with non-treated pre-existing conditions, which could be the cause of leg length differences
- Active osteomyelitis
- Ulcerations in the area of the skin of the surgical area
- Immunosuppressive drugs that can not be discontinued
Key Trial Info
Start Date :
August 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04067895
Start Date
August 6 2019
End Date
September 1 2024
Last Update
August 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital Vienna
Vienna, Austria, 1090